GSK Abreva Ad Claims Lack Supporting Data – Lawsuit

Data from studies measuring the efficacy of GlaxoSmithKline's OTC cold sore treatment Abreva do not substantiate ad claims for the product, Merix Pharmaceutical alleges in a false advertising suit

More from Archive

More from Pink Sheet